Category

Press Release

NeuroPace Launches Next Generation RNS System, the World’s Only Brain-Computer Interface for the Treatment of Refractory Epilepsy

By | Press Release | No Comments
Next Gen RNS System provides unprecedented brain data with long-lasting, 8-year battery life. MOUNTAIN VIEW, Calif -- June 1, 2018 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced the launch of its Next Gen RNS® System for the treatment of refractory epilepsy, which affects an estimated 1...
Read More

NeuroPace Unveils 8-Year Prospective Clinical Outcomes and Groundbreaking Research Using Deep Learning Algorithms to Identify Seizure Biomarkers

By | Press Release | No Comments

WASHINGTON–(EON: Enhanced Online News)–American Epilepsy Society Annual Meeting, Booth 1101–NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop brain-responsive neurostimulation system for epilepsy, today announces 5 poster presentations, including new 8-year prospective clinical trial data presented at the American Epilepsy Society’s (AES) Annual…

Read More

NeuroPace Launches New RNS® Tablet at 2017 American Epilepsy Society Annual Meeting

By | Press Release | No Comments

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop brain-responsive neurostimulation system for epilepsy, today announced the launch of the new RNS® Tablet—an innovative way for clinicians to review their patients’ electrocorticographic (ECoG) data and personalize therapy. The Tablet will…

Read More

NeuroPace Closes $74 Million Equity Funding to Accelerate Patient Access to the World’s First Brain-Responsive Neurostimulation System to Treat Epilepsy

By | Press Release, Uncategorized | No Comments

MOUNTAIN VIEW, Calif. – October 24, 2017 – NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop brain-responsive neurostimulation system shown to significantly reduce seizure frequency, announced today that it closed a $74 million round of funding led by the KCK Group and…

Read More